Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 606.33M | 535.08M | 451.36M | 366.1M | 295.52M | 233.67M | 182.95M | 129.62M | 83.37M | 42.56M | 17.45M | 14.37M | 12.5M | 27.78M | 25.82M | 16.15M | 17.39M | 24.13M | 57.03M | 56.69M | 55.45M | 33.43M |
Cost of Revenue | 57.03M | 51.15M | 46.97M | 40.97M | 19.62M | 16.38M | 12.83M | 9.12M | 6.25M | 3.56M | 2.16M | 1.35M | 1.18M | 1.39M | 1.17M | 742K | 596K | 811K | 2.08M | 2.1M | 2.03M | 1.3M |
Gross Profit | 549.3M | 483.93M | 404.39M | 325.13M | 275.91M | 217.29M | 170.13M | 120.51M | 77.12M | 39M | 15.28M | 13.02M | 11.32M | 26.39M | 24.65M | 15.41M | 16.8M | 23.32M | 54.95M | 54.59M | 53.41M | 32.13M |
Operating Income | -48.54M | -50.81M | -70.97M | -87.41M | -98.05M | -109.17M | -120.57M | -140.6M | -156.37M | -155.89M | -143.16M | -113.77M | -95.74M | -68.14M | -62.71M | -62.1M | -54.9M | -42.39M | -12.16M | -9.19M | -3.62M | -14.17M |
Interest Income | 15.48M | 16.02M | 15.75M | 15.44M | 15.45M | 15.35M | 15.01M | 14.35M | 13.07M | 11.16M | 10.34M | 9.49M | 7.71M | 5.78M | 3.49M | 1.37M | 317K | 27K | 36K | 34K | 30K | 36K |
Pretax Income | -44.05M | -48.56M | -64.36M | -81.16M | -91.99M | -104.94M | -115.55M | -134.34M | -150.07M | -148.21M | -135.89M | -107.59M | -90.96M | -65.28M | -62.1M | -63.29M | -56.82M | -44.7M | -13.77M | -10.44M | -4.54M | -14.17M |
Net Income | -46.48M | -48.27M | -66.42M | -81.16M | -91.99M | -104.94M | -115.55M | -134.34M | -150.07M | -148.21M | -135.89M | -107.59M | -90.95M | -65.27M | -62.09M | -63.34M | -56.53M | -44.49M | -13.96M | -10.58M | -5.02M | -14.57M |
Selling & General & Admin | 526.44M | 478.76M | 427.32M | 365.67M | 314.95M | 270.73M | 237.31M | 211.29M | 183.7M | 144.87M | 108.13M | 79.76M | 61.22M | 51.63M | 44.74M | 36.88M | 31.77M | 28.18M | 25.4M | 22.52M | 17.99M | 12.73M |
Research & Development | 87.68M | 72.26M | 64.32M | 63.16M | 59M | 55.73M | 53.39M | 49.82M | 49.8M | 50.02M | 50.31M | 47.04M | 45.84M | 42.9M | 42.62M | 40.63M | 39.93M | 37.53M | 41.71M | 41.26M | 39.04M | 33.58M |
Other Expenses | -16.28M | -16.28M | -16.28M | -16.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 597.84M | 534.74M | 475.36M | 412.55M | 373.95M | 326.46M | 290.7M | 261.1M | 233.49M | 194.89M | 158.44M | 126.79M | 107.06M | 94.53M | 87.36M | 77.51M | 71.7M | 65.72M | 67.11M | 63.78M | 57.04M | 46.3M |
Interest Expense | 8.61M | 8.55M | 8.5M | 8.46M | 8.66M | 8.67M | 7.58M | 6.4M | 4.94M | 3.65M | 3.35M | 3.05M | 2.82M | 2.55M | 2.19M | 1.49M | 860K | 316K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 654.87M | 585.89M | 522.33M | 453.51M | 393.57M | 342.84M | 303.52M | 270.22M | 239.75M | 198.45M | 160.61M | 128.14M | 108.24M | 95.92M | 88.53M | 78.25M | 72.29M | 66.53M | 69.18M | 65.88M | 59.07M | 47.6M |
Income Tax Expense | 2.42M | -293K | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -5K | -4K | 50K | -286K | -257K | 55K | 1K | 343K | 314K |
Shares Outstanding (Basic) | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M | 20.64M | 20.56M | 20.34M |
Shares Outstanding (Diluted) | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M | 20.64M | 21.97M | 21.82M |
EPS (Basic) | -1.09 | -1.14 | -1.62 | -2.02 | -2.33 | -2.73 | -3.10 | -3.81 | -4.48 | -4.77 | -4.64 | -3.86 | -3.42 | -2.49 | -2.59 | -2.78 | -2.70 | -2.15 | -0.66 | -0.50 | -0.28 | -0.89 |
EPS (Diluted) | -1.09 | -1.14 | -1.62 | -2.02 | -2.33 | -2.73 | -3.10 | -3.81 | -4.48 | -4.77 | -4.64 | -3.86 | -3.42 | -2.49 | -2.59 | -2.78 | -2.70 | -2.17 | -0.72 | -0.54 | -0.32 | -0.91 |
EBITDA | -35.22M | -40.18M | -55.88M | -72.59M | -81.14M | -94.43M | -106.46M | -126.66M | -144.07M | -143.55M | -131.73M | -103.98M | -87.73M | -62.41M | -59.63M | -61.58M | -55.7M | -44.05M | -13.37M | -10.05M | -4.22M | -14M |
EBIT | -37.56M | -41.98M | -57.69M | -74.39M | -82.78M | -95.86M | -107.71M | -127.82M | -145.17M | -144.59M | -132.61M | -104.6M | -88.21M | -62.8M | -59.96M | -61.85M | -55.96M | -44.38M | -13.77M | -10.45M | -4.56M | -14.19M |
Depreciation & Amortization | 2.34M | 1.79M | 1.82M | 1.81M | 1.65M | 1.43M | 1.24M | 1.16M | 1.1M | 1.04M | 877K | 628K | 478K | 388K | 325K | 267K | 256K | 333K | 399K | 399K | 340K | 188K |
Add to Watchlist
Select watchlists to add or remove TARS